Latest News about EXPERT ideas
Recent news which mentions EXPERT ideas
Top 4 Tech And Telecom Stocks That May Collapse This Month
November 04, 2024
From Benzinga
Here's Your Ultimate Trading Guide For The 2024 US Election
November 04, 2024
From Benzinga
Palantir Q3 Earnings On Deck As Cathie Wood Cuts Stake
November 04, 2024
From Benzinga
Top 4 Financials Stocks That Are Preparing To Pump In Q4
November 04, 2024
From Benzinga
10 Habits For A Richer, Happier Life
November 04, 2024
From Benzinga
Could Peloton Be Moving Away From DEI?
November 04, 2024
From Benzinga
ReconAfrica's Wild Ride: Promises Of 'Billions Of Barrels' And The Fracking Controversy
November 04, 2024
Tickers
RECAF
From Benzinga
Spain's Economy Outperforms Germany, France With Record Tourism
November 04, 2024
From Benzinga
Trump And Tesla: What The Future Holds For Elon Musk's EV Giant In Case Of A GOP Win
November 04, 2024
From Benzinga
US Stocks Likely To Open In Green Amid Hints Of Tentativeness On Election Eve: Expert Says Brace For Volatility Ahead Of Fed's Rate Decision
November 04, 2024
From Benzinga
Palantir Technologies Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Top Analysts
November 04, 2024
From Benzinga
Market Volatility Soars Ahead Of Elections, Tech Earnings Mixed, Strikes And Hurricanes Knock Employment Down: This Week In The Markets
November 01, 2024
From Benzinga
A Republican Sweep Might Be The Most Inflationary Election Outcome, Economists Warn
November 01, 2024
Tickers
ECON
From Benzinga
Stock Of The Day: Oil Climbs — And Chevron Follows Suit
November 01, 2024
From Benzinga
Bitcoin, Ethereum, Dogecoin End The Week Lower: 'Don't Get Shaken Out,' Trader Cautions
November 01, 2024
From Benzinga
Jim Cramer Said You 'Shouldn't Hold' Solana When It Traded At $11 In 2022—Now It's Trading At $166
November 01, 2024
Tickers
NEWS
From Benzinga
Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease
November 01, 2024
From Benzinga
Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious
November 01, 2024
From Benzinga
Shell Reports Strong Q3: Analysts Highlight Robust Buybacks Amid Market Challenges
November 01, 2024
From Benzinga
Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
November 01, 2024
From Benzinga
From Benzinga
ConocoPhillips-Marathon Synergy Will Boost Free Cash Flow And Stock Buyback: Analyst
November 01, 2024
From Benzinga
Amazon Analysts See Growth Ahead With AWS In 'Early Innings Of A Big AI Cycle,' Advertising Segment Fast-Growing 'Hidden Asset'
November 01, 2024
From Benzinga
Uber's Q3 Review: Analysts See Opportunity Amid Growth Slowdown, Strong Margins, And Expanding Autonomous Vehicle Partnerships
November 01, 2024
From Benzinga
Solana Sees $173M Funding Surge In Q3 Amid Rising Institutional Interest From PayPal, Visa, Franklin Templeton
November 01, 2024
Tickers
NEWS
From Benzinga
Bitcoin May End The Year At $79,000, Economist Predicts—But Here's How Different Election Outcomes Could Change That
November 01, 2024
From Benzinga
Intel Struggles With Market Share, Profitability: Q3 Analyst Insights
November 01, 2024
From Benzinga
Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry'
November 01, 2024
Tickers
ARGX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.